Tech Company Financing Transactions

Salient Surgical Funding Round

Salient Surgical secured a $20 million Series E investment round on 6/29/2007. Backers included TLM Investors and RiverVest Venture Partners.

Transaction Overview

Company Name
Announced On
6/29/2007
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series E
Investors

TLM Investors (Lead Investor) (Anthony Arnerich)

RiverVest Venture Partners

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
180 International Drive
Portsmouth, NH 03801
USA
Email Address
Overview
TissueLink Medical provides devices that reduce surgical blood loss. Utilizing TissueLink's saline-enhanced radio-frequency technology allows surgeons to control bleeding and improve patient outcomes.
Profile
Salient Surgical LinkedIn Company Profile
Social Media
Salient Surgical Company Twitter Account
Company News
Salient Surgical News
Facebook
Salient Surgical on Facebook
YouTube
Salient Surgical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Joseph Army
  Joseph Army LinkedIn Profile  Joseph Army Twitter Account  Joseph Army News  Joseph Army on Facebook
VP - Finance
Richard Altieri
  Richard Altieri LinkedIn Profile  Richard Altieri Twitter Account  Richard Altieri News  Richard Altieri on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/29/2007: CADForce venture capital transaction
Next: 6/29/2007: Mobius Power venture capital transaction

 

Share this article

 


News on VC Transactions

Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary